Listen to our latest Investing Matters Podcast episode 'Uncovering opportunities with investment trusts' with The AIC's Richard Stone here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Share News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,971.00
Bid: 1,971.00
Ask: 1,972.00
Change: -29.00 (-1.45%)
Spread: 1.00 (0.051%)
Open: 2,008.00
High: 2,012.00
Low: 1,958.00
Prev. Close: 2,000.00
HIK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Friday broker round-up UPDATE

Fri, 01st Aug 2014 10:33

AstraZeneca: Deutsche Bank ups target price from 3950p to 4000p staying with its hold recommendation.Avacta: Numis places both its target price and its buy recommendation under review.Barclays: Berenberg upgrades from sell to hold with a target price of 220p.Bodycote: UBS shifts target price from 860p to 865p and maintains a buy recommendation.Breedon: Berenberg initiates with a target price of 50p and a buy recommendation.Capita: Credit Suisse lowers target price from 1250p to 1215p and downgrades from outperform to neutral.Computacenter: Jefferies cuts target price from 720p to 690p retaining a hold recommendation.CVS Group: Berenberg starts with a target price of 410p and a buy recommendation.Daily Mail & General Trust: Numis shifts target price from 1180p to 1185p and stays with its buy recommendation.Diageo: Canaccord Genuity reduces target price from 1835p to 1540p downgrading from hold to sell.Dignity: Berenberg initiates with a target price of 1600p and a buy recommendation.Hikma Pharmaceuticals: Jefferies moves target price from 1600p to 1610p and keeps a hold recommendation.IMI: Investec places its target price (prev.: 1570p) under review, while leaving its buy recommendation unchanged.Informa: Goldman Sachs ups target price from 527p to 550p upgrading from sell to neutral.Intu Properties: Deutsche Bank moves target price from 270p to 280p and maintains a hold recommendation.Lancashire Holdings: Credit Suisse reduces target price from 800p to 680p, while leaving its outperform rating unaltered.Lloyds Banking Group: Deutsche Bank shifts target price from 87p to 89p and keeps a buy recommendation.Man Group: Panmure Gordon downgrades from buy to hold with a target price of 125p.Micro Focus: Jefferies raises target price from 420p to 635p, while maintaining an underperform rating.Next: Berenberg raises target price from 7740p to 8075p maintaining a buy recommendation.Parkmead: Numis initiates with a target price of 262p and a buy recommendation.Pennon Group: Credit Suisse moves target price from 645p to 655p and reiterates an underperform rating.PZ Cussons: Panmure Gordon moves target price from 400p to 410p retaining a buy recommendation.Randgold Resources: UBS downgrades from buy to neutral with a target price of 5400p. RBC Capital reduces target price from 5300p to 5200p and stays with a neutral rating.Rightmove: Jefferies reduces target price from 2260p to 2177p keeping a hold recommendation.Rolls-Royce Group: Deutsche Bank cuts target price from 900p to 860p retaining its sell recommendation.Royal Bank of Scotland: Investec ups target price from 325p to 340p, while downgrading from hold to sell.Royal Dutch Shell: Jefferies increases target price from 2460p to 2730p upgrading from hold to buy. UBS raises target price from 2300p to 2450p staying with its neutral rating.RPS Group: Jefferies reduces target price from 385p to 320p, while leaving its buy recommendation unchanged.Schroders: Jefferies raises target price from 2300p to 2500p and reiterates a hold recommendation. Numis cuts target price from 3087p to 3042p retaining its buy recommendation.SDL: Jefferies reduces target price from 620p to 480p, while keeping a buy recommendation.Severn Trent: Credit Suisse increases target price from 1540p to 1730p upgrading to neutral.Smith & Nephew: Investec downgrades from buy to add with a target price of 1100p.UBM: Canaccord Genuity cuts target price from 725p to 680p and retains a hold recommendation.United Utilities: Credit Suisse raises target price from 680p to 730p, while downgrading to underperform.Vesuvius: Investec places both its target price (prev.: 465p) and its add rating under review.Weir Group: Morgan Stanley raises target price from 2440p to 2510p and keeps an equal-weight rating.Zoopla Property: Jefferies initiates with a target price of 325p and a buy recommendation.
More News
29 Feb 2024 09:18

LONDON BROKER RATINGS: Barclays cuts Direct Line to equal weight

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning:

Read more
29 Feb 2024 07:45

LONDON BRIEFING: Stocks called up following slew of FTSE 100 earnings

(Alliance News) - Stocks in London are called to open slightly higher on Thursday, after a slew of earnings from a range of FTSE 100 companies.

Read more
27 Feb 2024 09:40

Berenberg slightly raises target price on Hikma Pharmaceuticals

(Sharecast News) - Analysts at Berenberg raised their target price on drugmaker Hikma Pharmaceuticals from 1,960.0p to 2,000.0p on Tuesday, citing more stability in its generics unit.

Read more
23 Feb 2024 09:19

LONDON BROKER RATINGS: Barclays raises Breedon but cuts Domino's Pizza

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and Thursday:

Read more
22 Feb 2024 16:26

London close: Stocks rise amid raft of solid earnings

(Sharecast News) - London's stock markets finished in positive territory on Thursday, bolstered by upbeat performances from US AI chipmaker Nvidia and engine manufacturer Rolls-Royce.

Read more
22 Feb 2024 09:49

LONDON BROKER RATINGS: Berenberg raises Moneysupermarket.com to 'buy'

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

Read more
22 Feb 2024 09:42

TOP NEWS: Hikma boosts dividend after year of "significant progress"

(Alliance News) - Shares in Hikma Pharmaceuticals PLC jumped on Thursday after it lifted the dividend by 29% amid better-than-expected annual profit.

Read more
22 Feb 2024 07:51

Hikma lifts dividend after double-digit growth in 2023

(Sharecast News) - Hikma Pharmaceuticals impressed the market with its annual results on Thursday as it bumped up its dividend by almost a third following double-digit growth in core revenues and profits in 2023.

Read more
15 Feb 2024 14:42

UK earnings, trading statements calendar - next 7 days

Friday 16 February 
NatWest Group PLCFull Year Results
Segro PLCFull Year Results
TBC Bank Group PLCFull Year Results
Monday 19 February 
Bank of Cyprus Holdings PLCFull Year Results
MoneySupermarket.com PLCFull Year Results
Transense Technologies PLCHalf Year Results
Wilmington PLCHalf Year Results
Tuesday 20 February 
Antofagasta PLCFull Year Results
Barclays PLCFull Year Results
BHP Group LtdHalf Year Results
Coca-Cola Europacific Partners PLCFull Year Results
Gran Tierra Energy IncFull Year Results
InterContinental Hotels Group PLCFull Year Results
Petra Diamonds LtdHalf Year Results
Springfield Properties PLCHalf Year Results
Wednesday 21 February 
BAE Systems PLCFull Year Results
Conduit Holdings LtdFull Year Results
Glencore PLCFull Year Results
HSBC Holdings PLCFull Year Results
Rio Tinto PLCFull Year Results
Riverstone Credit Opportunities Income PLCFull Year Results
Tate & Lyle PLCTrading Statement
Thursday 22 February 
Anglo American PLCFull Year Results
Genus PLCHalf Year Results
Hargreaves Lansdown PLCHalf Year Results
Hays PLCHalf Year Results
Hikma Pharmaceuticals PLCFull Year Results
Indivior PLCFull Year Results
Jupiter Fund Management PLCFull Year Results
Lloyds Banking Group PLCFull Year Results
ME Group International PLCFull Year Results
Morgan Sindall Group PLCFull Year Results
Pantheon International PLCHalf Year Results
Rolls-Royce Holdings PLCFull Year Results
WPP PLCFull Year Results
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
2 Feb 2024 07:23

Hikma agrees to settle US opioid claims

(Sharecast News) - Hikma Pharmaceuticals announced an agreement in principle to address the majority of opioid-related claims filed against it by various US states, local communities and tribal nations on Friday.

Read more
1 Feb 2024 20:00

EARNINGS AND TRADING: Tandem FY sales down 17%; Hikma's opioid deal

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more
9 Jan 2024 09:29

LONDON BROKER RATINGS: Berenberg cuts target prices for miners

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Wednesday:

Read more
20 Dec 2023 09:25

LONDON BROKER RATINGS: UBS cuts DS Smith; Kepler likes Genus

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
19 Dec 2023 09:11

LONDON BROKER RATINGS: Peel Hunt raises Flutter to 'buy' from 'hold'

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
5 Dec 2023 10:02

LONDON BROKER RATINGS: Goldman lifts Landsec and British Land

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.